New Delhi: Drug firm Zydus Cadila today said it has received the US health regulator`s approval to market aripiprazole orally disintegrating tablets, used in treating schizophrenia, in the American market. The company has received a tentative approval from the US Food and Drug Administration for aripiprazole orally disintegrating tablets in the strengths of 10 mg, 15 mg, 20 mg and 30 mg, Zydus Cadila said in a statement.
60 days of Narendra Modi governmnet
Ex PM seeks probe after Gadkari dismisses bugging claim
Kick: A perfect gift for Salman Khan`s fans
Delhi auto drivers on a day long strike against Delhi Police